GOP Leadership Tells Party To Keep Quiet On Pelosi Rx Pricing Bill

By John Wilkerson / September 12, 2019 at 10:14 AM
The top Republican on the House Ways & Means Committee was twice given the chance Wednesday (Sept. 11) to attack House Speaker Nancy Pelosi’s draft Medicare drug price negotiation bill, and twice Rep. Kevin Brady demurred. The Texas lawmaker’s uncharacteristic diplomatic treatment of government price controls is the result of a directive from GOP leadership to withhold comment on Pelosi’s bill, a Republican lobbyist said. “As far as Speaker Pelosi, again, we are open to finding common ground,” Brady said...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.